The DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
Review of hybrid PLGA nanoparticles: Future of smart drug delivery and theranostics medicine
Open accessAbstract
The concept of PLGA-lipid hybrid nanoparticles arose as a motivation for developing drug delivery systems with versatile physical and chemical properties, unequivocal therapeutic benefits and minimized side effects. These formulations opened a new avenue of “smart tools” in the development of personalized, noninvasive emerging nanomedicine. However, there is still the risk that smart hybrid system manufactured from a mixture of materials, such as PLGA in combination with synthetic/vegetable lipids and targeting agents might trigger high nanotoxicological responses. This review is focused on the detailed description of PLGA-lipids/oils hybridization concept and its effect on the performances of nanocarriers as powerful, versatile delivery system, the manufacturing methods, the main applications, and their potential clinical impact. The successful design of a hybrid formulation involves two foremost challenges, firstly a comprehensive consideration of essential characteristics of each constituent that form the hybrid system and secondly, a deep understanding of the interactions of hybrid nanocarrier with cells in order to predict the potential toxicity issues and ensure its safe clinical applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
Makadia, H. K., & Siegel, S. J. (2011) · Polymers · doi:10.3390/polym3031377 · Cited by 4,816
PLGA-based nanoparticles: An overview of biomedical applications
Danhier, F., Ansorena, E., Silva, J. M., Coco, R., Le Breton, A., & Préat, V. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.043 · Cited by 3,806
Kamaly, N., Yameen, B., Wu, J., & Farokhzad, O. C. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00346 · Cited by 3,070
Biodegradation and biocompatibility of PLA and PLGA microspheres
Anderson, J. M., & Shive, M. S. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00048-3 · Cited by 2,617
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
Bobo, D., Robinson, K. J., Islam, J., Thurecht, K. J., & Corrie, S. R. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-1958-5 · Cited by 2,586
Applications of nanoparticle systems in drug delivery technology
Rizvi, S. A. A., & Saleh, A. M. (2018) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2017.10.012 · Cited by 1,334
Anselmo, A. C., & Mitragotri, S. (2016) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10003 · Cited by 1,321
Self-Assembled Lipid−Polymer Hybrid Nanoparticles: A Robust Drug Delivery Platform
Zhang, L., Chan, J. M., Gu, F. X., Rhee, J.-W., Wang, A. Z., Radovic-Moreno, A. F., Alexis, F., Langer, R., & Farokhzad, O. C. (2008) · ACS Nano · doi:10.1021/nn800275r · Cited by 1,038
Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system
Sengupta, S., Eavarone, D., Capila, I., Zhao, G., Watson, N., Kiziltepe, T., & Sasisekharan, R. (2005) · Nature · doi:10.1038/nature03794 · Cited by 945
Immunomodulatory and therapeutic properties of the Nigella sativa L. seed
Salem, M. L. (2005) · International Immunopharmacology · doi:10.1016/j.intimp.2005.06.008 · Cited by 853
Antibody-Drug Conjugates in Cancer Therapy
Sievers, E. L., & Senter, P. D. (2013) · Annual Review of Medicine · doi:10.1146/annurev-med-050311-201823 · Cited by 770
PLGA Nanoparticles in Drug Delivery: The State of the Art;
Bala, I., Hariharan, S., & Kumar, M. R. (2004) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v21.i5.20 · Cited by 739
Mu, L., & Feng, S. S. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00320-6 · Cited by 725
Lipid–polymer hybrid nanoparticles as a new generation therapeutic delivery platform: A review
Hadinoto, K., Sundaresan, A., & Cheow, W. S. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.07.002 · Cited by 702
PLGA–lecithin–PEG core–shell nanoparticles for controlled drug delivery
Chan, J. M., Zhang, L., Yuet, K. P., Liao, G., Rhee, J.-W., Langer, R., & Farokhzad, O. C. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.12.013 · Cited by 702
Duch, M. C., Budinger, G. R. S., Liang, Y. T., Soberanes, S., Urich, D., Chiarella, S. E., Campochiaro, L. A., Gonzalez, A., Chandel, N. S., Hersam, M. C., et al. (2011) · Nano Letters · doi:10.1021/nl202515a · Cited by 546
An overview of clinical and commercial impact of drug delivery systems
Anselmo, A. C., & Mitragotri, S. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.053 · Cited by 520
Oral delivery of anticancer drugs: Challenges and opportunities
Thanki, K., Gangwal, R. P., Sangamwar, A. T., & Jain, S. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.04.020 · Cited by 499
Mukherjee, A., Waters, A. K., Kalyan, P., Achrol, A. S., Kesari, S., & Yenugonda, V. M. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s198353 · Cited by 493
Tunable Rigidity of (Polymeric Core)–(Lipid Shell) Nanoparticles for Regulated Cellular Uptake
Sun, J., Zhang, L., Wang, J., Feng, Q., Liu, D., Yin, Q., Xu, D., Wei, Y., Ding, B., Shi, X., et al. (2015) · Advanced Materials · doi:10.1002/adma.201404788 · Cited by 486
Polymeric nanoparticles: the future of nanomedicine
Banik, B. L., Fattahi, P., & Brown, J. L. (2016) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1364 · Cited by 485
Core–shell-type lipid–polymer hybrid nanoparticles as a drug delivery platform
Mandal, B., Bhattacharjee, H., Mittal, N., Sah, H., Balabathula, P., Thoma, L. A., & Wood, G. C. (2013) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2012.11.010 · Cited by 467
Polymeric nanoparticles for targeted treatment in oncology: current insights
Joshi, M. D., Patravale, V., & Prabhu, R. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s56932 · Cited by 438
Recent advances of PLGA micro/nanoparticles for the delivery of biomacromolecular therapeutics
Ding, D., & Zhu, Q. (2018) · Materials Science and Engineering: C · doi:10.1016/j.msec.2017.12.036 · Cited by 386
Nanoparticles by spray drying using innovative new technology: The Büchi Nano Spray Dryer B-90
Li, X., Anton, N., Arpagaus, C., Belleteix, F., & Vandamme, T. F. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.07.113 · Cited by 379
Mornet, S., Lambert, O., Duguet, E., & Brisson, A. (2005) · Nano Letters · doi:10.1021/nl048153y · Cited by 367
Fluorinated Graphene for Promoting Neuro‐Induction of Stem Cells
Wang, Y., Lee, W. C., Manga, K. K., Ang, P. K., Lu, J., Liu, Y. P., Lim, C. T., & Loh, K. P. (2012) · Advanced Materials · doi:10.1002/adma.201200846 · Cited by 347
Liu, Y., Li, K., Pan, J., Liu, B., & Feng, S.-S. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.09.036 · Cited by 342
PLGA-based nanoparticles: A new paradigm in biomedical applications
Sharma, S., Parmar, A., Kori, S., & Sandhir, R. (2016) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2015.06.014 · Cited by 340
Graphene-based nanomaterials for drug and/or gene delivery, bioimaging, and tissue engineering
Zhao, H., Ding, R., Zhao, X., Li, Y., Qu, L., Pei, H., Yildirimer, L., Wu, Z., & Zhang, W. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.04.002 · Cited by 336
Factors affecting drug encapsulation and stability of lipid–polymer hybrid nanoparticles
Cheow, W. S., & Hadinoto, K. (2011) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2011.02.033 · Cited by 297
When stem cells meet graphene: Opportunities and challenges in regenerative medicine
Kenry, Lee, W. C., Loh, K. P., & Lim, C. T. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2017.10.004 · Cited by 293
A Comprehensive Map of FDA-Approved Pharmaceutical Products
Zhong, H., Chan, G., Hu, Y., Hu, H., & Ouyang, D. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10040263 · Cited by 288
In Vitro and in Vivo mRNA Delivery Using Lipid-Enveloped pH-Responsive Polymer Nanoparticles
Su, X., Fricke, J., Kavanagh, D. G., & Irvine, D. J. (2011) · Molecular Pharmaceutics · doi:10.1021/mp100390w · Cited by 287
Anticancer Activity of Nigella sativa (Black Seed) — A Review
Randhawa, M. A., & Alghamdi, M. S. (2011) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x1100941x · Cited by 272
Lipid-polymer hybrid nanoparticles: Synthesis strategies and biomedical applications
Dave, V., Tak, K., Sohgaura, A., Gupta, A., Sadhu, V., & Reddy, K. R. (2019) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2019.03.017 · Cited by 241
Graphene-based electrochemical biosensors for monitoring noncommunicable disease biomarkers
Taniselass, S., Arshad, M. K. M., & Gopinath, S. C. B. (2019) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2019.01.047 · Cited by 238
Kim, Y., Lee Chung, B., Ma, M., Mulder, W. J. M., Fayad, Z. A., Farokhzad, O. C., & Langer, R. (2012) · Nano Letters · doi:10.1021/nl301253v · Cited by 234
Concepts and practices used to develop functional PLGA-based nanoparticulate systems
Sah, H., Desu, Sah, Wood, & Thoma (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s40579 · Cited by 217
Progress in utilisation of graphene for electrochemical biosensors
Lawal, A. T. (2018) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2018.01.030 · Cited by 210
PLGA/polymeric liposome for targeted drug and gene co-delivery
Wang, H., Zhao, P., Su, W., Wang, S., Liao, Z., Niu, R., & Chang, J. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.07.082 · Cited by 209
Fang, R. H., Aryal, S., Hu, C.-M. J., & Zhang, L. (2010) · Langmuir · doi:10.1021/la103576a · Cited by 206
Steric Stabilization of Lipid/Polymer Particle Assemblies by Poly(ethylene glycol)-Lipids
Thevenot, J., Troutier, A.-L., David, L., Delair, T., & Ladavière, C. (2007) · Biomacromolecules · doi:10.1021/bm700753q · Cited by 198
Shi, J., Xiao, Z., Votruba, A. R., Vilos, C., & Farokhzad, O. C. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201101554 · Cited by 196
Delivery of Multiple siRNAs Using Lipid-Coated PLGA Nanoparticles for Treatment of Prostate Cancer
Hasan, W., Chu, K., Gullapalli, A., Dunn, S. S., Enlow, E. M., Luft, J. C., Tian, S., Napier, M. E., Pohlhaus, P. D., Rolland, J. P., et al. (2012) · Nano Letters · doi:10.1021/nl2035354 · Cited by 187
Engineered PLGA nano- and micro-carriers for pulmonary delivery: challenges and promises
Ungaro, F., d' Angelo, I., Miro, A., La Rotonda, M. I., & Quaglia, F. (2012) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2012.01486.x · Cited by 183
Combinatorial Drug Conjugation Enables Nanoparticle Dual‐Drug Delivery
Aryal, S., Hu, C. J., & Zhang, L. (2010) · Small · doi:10.1002/smll.201000631 · Cited by 183
Nanotherapy for Cancer: Targeting and Multifunctionality in the Future of Cancer Therapies
Ediriwickrema, A., & Saltzman, W. M. (2015) · ACS Biomaterials Science & Engineering · doi:10.1021/ab500084g · Cited by 183
Novel Targeted Therapies for Inflammatory Bowel Disease
Coskun, M., Vermeire, S., & Nielsen, O. H. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.10.014 · Cited by 178
Application of Nanotechnology in Drug Delivery
Silva, J., Fernandes, A. R., & Baptista, P. V. (2014) · Application of Nanotechnology in Drug Delivery · doi:10.5772/58424 · Cited by 176
Wang, Y., Kho, K., Cheow, W. S., & Hadinoto, K. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.12.045 · Cited by 176
Graphene: A versatile platform for nanotheranostics and tissue engineering
Geetha Bai, R., Ninan, N., Muthoosamy, K., & Manickam, S. (2018) · Progress in Materials Science · doi:10.1016/j.pmatsci.2017.08.004 · Cited by 171
Vey, E., Rodger, C., Booth, J., Claybourn, M., Miller, A. F., & Saiani, A. (2011) · Polymer Degradation and Stability · doi:10.1016/j.polymdegradstab.2011.07.011 · Cited by 164
Polymer Nanoparticles for Smart Drug Delivery
Bennet, D., & Kim, S. (2014) · Application of Nanotechnology in Drug Delivery · doi:10.5772/58422 · Cited by 161
LIPID–POLYMER HYBRID NANOPARTICLES: SYNTHESIS, CHARACTERIZATION AND APPLICATIONS
Zhang, L., & Zhang, L. (2010) · Nano LIFE · doi:10.1142/s179398441000016x · Cited by 156
Molavi, F., Barzegar-Jalali, M., & Hamishehkar, H. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.01.028 · Cited by 154
Hybrid poly(lactic-co-glycolic acid) nanoparticles: design and delivery prospectives
Pandita, D., Kumar, S., & Lather, V. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.09.018 · Cited by 153
PLGA micro and nanoparticles in delivery of peptides and proteins; problems and approaches
Mohammadi‐Samani, S., & Taghipour, B. (2014) · Pharmaceutical Development and Technology · doi:10.3109/10837450.2014.882940 · Cited by 149
Zhao, P., Wang, H., Yu, M., Liao, Z., Wang, X., Zhang, F., Ji, W., Wu, B., Han, J., Zhang, H., et al. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.03.004 · Cited by 147
Silva, J. M., Zupančič, E., Vandermeulen, G., Oliveira, V. G., Salgado, A., Videira, M., Gaspar, M. M., Graça, L., Véronique Préat, A., & Florindo, H. F. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.11.033 · Cited by 146
Kong, S. D., Zhang, W., Lee, J. H., Brammer, K. S., Lal, R., Karin, M., & Jin, S. (2010) · Nano Letters · doi:10.1021/nl1033733 · Cited by 144
Tahir, N., Madni, A., Balasubramanian, V., Rehman, M., Correia, A., Kashif, P. M., Mäkilä, E. M., Salonen, J., & Santos, H. A. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.09.061 · Cited by 144
Chan, J. M., Rhee, J., Drum, C. L., Bronson, R. T., Golomb, G., Langer, R., & Farokhzad, O. C. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115945108 · Cited by 143
Zheng, Y., Yu, B., Weecharangsan, W., Piao, L., Darby, M. V., Mao, Y., Koynova, R. D., Yang, X., Li, H., Xu, S., et al. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.02.008 · Cited by 143
Poly(lactic acid)/poly(lactic-co-glycolic acid) particulate carriers for pulmonary drug delivery
Emami, F., Yazdi, S. J. M., & Na, D. H. (2019) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-019-00443-1 · Cited by 142
Ling, G., Zhang, P., Zhang, W., Sun, J., Meng, X., Qin, Y., Deng, Y., & He, Z. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.010 · Cited by 136
Yu, F., Ao, M., Zheng, X., Li, N., Xia, J., Yang, L., Li, D., Hou, Z., Qi, Z., & Chen, X. D. (2017) · Drug Delivery · doi:10.1080/10717544.2017.1321062 · Cited by 136
Lipid-enveloped hybrid nanoparticles for drug delivery
Tan, S., Li, X., Guo, Y., & Zhang, Z. (2012) · Nanoscale · doi:10.1039/c2nr32880a · Cited by 134
Magnetic field activated lipid–polymer hybrid nanoparticles for stimuli-responsive drug release
Kong, S. D., Sartor, M., Hu, C. J., Zhang, W., Zhang, L., & Jin, S. (2012) · Acta Biomaterialia · doi:10.1016/j.actbio.2012.11.006 · Cited by 129
Rao, S., & Prestidge, C. A. (2016) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2016.1151872 · Cited by 128
Systemic delivery to central nervous system by engineered PLGA nanoparticles.
Cai, Q., Wang, L., Deng, G., Liu, J., Chen, Q., & Chen, Z. (2016) · PubMed · Cited by 124
Synthesis of Polymer–Lipid Nanoparticles for Image-Guided Delivery of Dual Modality Therapy
Mieszawska, A. J., Kim, Y., Gianella, A., van Rooy, I., Priem, B., Labarre, M. P., Ozcan, C., Cormode, D. P., Petrov, A. D., Langer, R., et al. (2013) · Bioconjugate Chemistry · doi:10.1021/bc400166j · Cited by 122
Folate-modified lipid–polymer hybrid nanoparticles for targeted paclitaxel delivery
Zhu, D., Zhang, L., Dong, X., Sun, H., Song, C. X., Wang, C., & Kong, D. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s77667 · Cited by 120
Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery
Hallan, S. S., Kaur, P., Kaur, V., Mishra, N., & Vaidya, B. (2014) · Artificial Cells Nanomedicine and Biotechnology · doi:10.3109/21691401.2014.951721 · Cited by 117
Physicochemical and Interfacial Investigation of Lipid/Polymer Particle Assemblies
Troutier, A., Delair, T., Pichot, C., & Ladavière, C. (2005) · Langmuir · doi:10.1021/la047659t · Cited by 112
Wang, A. Z., Yuet, K. P., Zhang, L., et al. (2010) · Nanomedicine · doi:10.2217/nnm.10.6 · Cited by 110
Niu, M., Naguib, Y. W., Aldayel, A. M., Shi, Y.-C., Hursting, S. D., Hersh, M. A., & Cui, Z. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500565q · Cited by 110
Lipid-based surface engineering of PLGA nanoparticles for drug and gene delivery applications
Bose, R. J., Lee, S.-H., & Park, H. (2016) · Biomaterials Research · doi:10.1186/s40824-016-0081-3 · Cited by 109
Xie, S., Wang, S., Zhao, B., Han, C., Wang, M., & Zhou, W. (2008) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2008.08.018 · Cited by 104
Liu, L., Ma, P., Wang, H., Zhang, C., Sun, H., Wang, C., Song, C. X., Leng, X., Kong, D., & Ma, G. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.050 · Cited by 103
Effect of drug release kinetics on nanoparticle therapeutic efficacy and toxicity
Sethi, M., Sukumar, R., Karve, S., Werner, M. E., Wang, E. C., Moore, D. T., Kowalczyk, S. R., Zhang, L., & Wang, A. Z. (2014) · Nanoscale · doi:10.1039/c3nr05961h · Cited by 102
Hu, Y. Y., Hoerle, R., Ehrich, M. F., & Zhang, C. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.09.032 · Cited by 102
Hybrid lipid–polymer nanoparticles for sustained siRNA delivery and gene silencing
Shi, J., Xu, Y., Xu, X., Zhu, X. D., Pridgen, E. M., Wu, J., Votruba, A. R., Swami, A., Zetter, B. R., & Farokhzad, O. C. (2014) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.03.006 · Cited by 102
Mieszawska, A. J., Gianella, A., Cormode, D. P., Zhao, Y., Meijerink, A., Langer, R., Farokhzad, O. C., Fayad, Z. A., & Mulder, W. J. M. (2012) · Chemical Communications · doi:10.1039/c2cc32149a · Cited by 102
Shirvalilou, S., Khoei, S., Khoee, S., Raoufi, N. J., Karimi, M. R., & Shakeri‐Zadeh, A. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.08.027 · Cited by 102
Synthesis and Assembly of Click‐Nucleic‐Acid‐Containing PEG–PLGA Nanoparticles for DNA Delivery
Harguindey, A., Domaille, D. W., Fairbanks, B. D., Wagner, J., Bowman, C. N., & Cha, J. N. (2017) · Advanced Materials · doi:10.1002/adma.201700743 · Cited by 97
Rose, F., Wern, J. E., Ingvarsson, P. T., van de Weert, M., Andersen, P. L., Follmann, F., & Foged, C. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.05.004 · Cited by 95
Strategies for optimizing polymer-lipid hybrid nanoparticle-mediated drug delivery
Wu, X. Y. (2016) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2016.1165662 · Cited by 95
Polymer-supported lipid shells, onions, and flowers
Bershteyn, A., Chaparro, J., Yau, R. G., Kim, M., Reinherz, E. L., Moita, L. F., & Irvine, D. J. (2008) · Soft Matter · doi:10.1039/b804933e · Cited by 92
Wang, Q., Alshaker, H. A., Böhler, T., Srivats, S., Chao, Y., Cooper, C., & Pchejetski, D. (2017) · Scientific Reports · doi:10.1038/s41598-017-06142-x · Cited by 91
Wang, G., Yu, B., Wu, Y., Huang, B., Yuan, Y., & Liu, C. S. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.02.004 · Cited by 90
Shin, Y. C., Kim, J., Kim, S. E., Song, S.-J., Hong, S. W., Oh, J., Lee, J., Park, J., Hyon, S.-H., & Han, D. (2017) · Regenerative Biomaterials · doi:10.1093/rb/rbx001 · Cited by 89
Biomedical Applications of Functionalized Nanomaterials
(2018) · Elsevier eBooks · doi:10.1016/c2016-0-01449-3 · Cited by 88
Agrawal, U., Chashoo, G., Sharma, P. R., Kumar, A., Saxena, A. K., & Vyas, S. P. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.12.045 · Cited by 84
Graphene-Based Nanomaterials in Bioimaging
Lin, J., Huang, Y., & Huang, P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-50878-0.00009-4 · Cited by 84
Self-assembled hybrid nanoparticles for targeted co-delivery of two drugs into cancer cells
Huang, F., You, M., Chen, T., Zhu, G., Liang, H., & Tan, W. (2014) · Chemical Communications · doi:10.1039/c3cc49003c · Cited by 83
Shi, K., Zhou, J., Zhang, Q., Gao, H., Liu, Y., Zong, T., & He, Q. (2014) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2015.1965 · Cited by 64
Zhao, J., Zhang, X., Sun, X., Zhao, M., Yu, C., Lee, R. J., Sun, F., Zhou, Y., Li, Y., & Teng, L. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.06.020 · Cited by 64
Youn, Y. S., Choi, J. S., Lee, C., Kim, I.-S., Oh, K. T., Lee, Lee, K. C., & Park, E. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s48197 · Cited by 63
Devrim, B., Kara, A., Vural, İ., & Bozkır, A. (2016) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2016.1180392 · Cited by 62
Design of soft lipid nanocarriers based on bioactive vegetable oils with multiple health benefits
Lăcătuşu, I., Niculae, G., Badea, N. M., Stan, R., Popa, O., Oprea, O., & Meghea, A. (2014) · Chemical Engineering Journal · doi:10.1016/j.cej.2014.02.041 · Cited by 61
Self-citationŞengel-Türk, C. T., & Hasçiçek, C. (2017) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2017.02.012 · Cited by 60
Polymer-lipid-PEG hybrid nanoparticles as photosensitizer carrier for photodynamic therapy
Pramual, S., Lirdprapamongkol, K., Svasti, J., Bergkvist, M., Jouan–Hureaux, V., Arnoux, P., Frochot, C., Barberi‐Heyob, M., & Niamsiri, N. (2017) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2017.05.028 · Cited by 55
An update on polymer-lipid hybrid systems for improving oral drug delivery
Maghrebi, S., Prestidge, C. A., & Joyce, P. M. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1605353 · Cited by 55
García-Díaz, M., Foged, C., & Nielsen, H. M. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.11.047 · Cited by 54
Hu, Y. Y., Ehrich, M. F., Fuhrman, K., & Zhang, C. (2014) · Nanoscale Research Letters · doi:10.1186/1556-276x-9-434 · Cited by 53
Narvekar, M., Xue, H. Y., & Wong, H. L. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.07.042 · Cited by 52
Shirvalilou, S., Khoei, S., Khoee, S., Mahdavi, S. R., Raoufi, N. J., Motevalian, M., & Karimi, M. Y. (2020) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2020.111827 · Cited by 52
Optimization of DNA delivery by three classes of hybrid nanoparticle/DNA complexes
Zhong, Q., Chinta, D. M. D., Pamujula, S., Wang, H., Yao, X., Mandal, T. K., & Luftig, R. B. (2010) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-8-6 · Cited by 50
Polymeric Lipid Hybrid Nanoparticles: Properties and Therapeutic Applications
Jose, C., Amra, K., Bhavsar, C., Momin, M. M., & Omri, A. (2018) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.2018024751 · Cited by 49
Xin, Y., Liu, T., & Yang, C. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s119999 · Cited by 46
Yang, Z., Tang, W., Luo, X., Zhang, X., Zhang, C., Li, H., Gao, D., Luo, H., Jiang, Q. Y., & Liu, J. (2014) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2015.2086 · Cited by 44
Doolaanea, A. A., Mansor, N. I., Nor, N. H. M., & Mohamed, F. (2016) · Journal of Microencapsulation · doi:10.3109/02652048.2015.1134689 · Cited by 39
Reginald, L. D. (2005) · Frontiers in bioscience · doi:10.2741/1559 · Cited by 37
Lipid polymer hybrid nanospheres encapsulating antiproliferative agents for stent applications
Bose, R. J., Lee, S., & Park, H. (2016) · Journal of Industrial and Engineering Chemistry · doi:10.1016/j.jiec.2016.02.015 · Cited by 36
Kargar, S., Khoei, S., Khoee, S., Shirvalilou, S., & Mahdavi, S. R. (2017) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2017.11.007 · Cited by 36
Li, Q., Xia, D., Tao, J., Shen, A., He, Y., Gan, Y., & Wang, C. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.05.029 · Cited by 33
Ghițman, J., Stan, R., Ghebaur, A., Cecoltan, S., Vasile, E., & Iovu, H. (2018) · Polymers · doi:10.3390/polym10060579 · Cited by 33
Self-citationFahmy, S. A., & Mamdouh, W. (2018) · Journal of Applied Polymer Science · doi:10.1002/app.46133 · Cited by 32
Biocompatible PLGA-oil hybrid nanoparticles for high loading and controlled delivery of resveratrol
Kumar, S., Sangwan, P., Lather, V., & Pandita, D. (2015) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2015.09.016 · Cited by 30
Narvekar, M., Xue, H. Y., Tran, N. T., Mikhael, M., & Wong, H. L. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.04.014 · Cited by 29
Feng, W., Guo, H., Xue, T., Wang, X., Tang, C., Bao, Y., Gong, H., & Cui, G. (2015) · RSC Advances · doi:10.1039/c5ra17686g · Cited by 29
Hybrid Nano-carriers for Potential Drug Delivery
Madni, A., Tahir, N., Rehman, M., Raza, A., Mahmood, M. A., Khan, M. I., & Kashif, P. M. (2017) · InTech eBooks · doi:10.5772/66466 · Cited by 28
Joyce, P. M., Yasmin, R., Bhatt, A., Boyd, B. J., Pham, A. C., & Prestidge, C. A. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00676 · Cited by 27
Joyce, P. M., & Prestidge, C. A. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.03.018 · Cited by 27
Inhibition of hemangioma growth using polymer–lipid hybrid nanoparticles for delivery of rapamycin
Li, H., Teng, Y., Sun, J., & Liu, J. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.08.035 · Cited by 24
Lipid‐enveloped PLGA as a hybrid carrier for sustained delivering camptothecin in ovarian cancer
Lin, Y., Gao, M., Wu, Y., et al. (2017) · IET Nanobiotechnology · doi:10.1049/iet-nbt.2016.0141 · Cited by 12
Hybrid nanocarriers based on PLGA-vegetable oil: A novel approach for high lipophilic drug delivery
Ghițman, J., Stan, R., Cecoltan, S., Chifiriuc, M. C., & Iovu, H. (2018) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2018.05.012 · Cited by 10
Self-citationZhu, L. Y., Xie, S., Dong, Z., Wang, X. Q., Wang, Y., & Zhou, W. (2011) · IET Nanobiotechnology · doi:10.1049/iet-nbt.2010.0041 · Cited by 9
Investigation the molecular structure of novel graphene hybrid scaffold in nerve regeneration
Askari, N., Askari, M. B., & Shafieipour, A. (2019) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2019.03.058 · Cited by 8
Cited by
Optical Properties and Applications of Plasmonic‐Metal Nanoparticles
Wang, L., Hasanzadeh Kafshgari, M., & Meunier, M. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202005400 · Cited by 630
Recent Progress in Nanostructured Smart Drug Delivery Systems for Cancer Therapy: A Review
Khan, M. I., Hossain, M. I., Hossain, M. K., Rubel, M. H. K., Hossain, K. M., Mahfuz, A. M. U. B., & Anik, M. I. (2022) · ACS Applied Bio Materials · doi:10.1021/acsabm.2c00002 · Cited by 370
Exosome engineering in cell therapy and drug delivery
Sadeghi, S., Tehrani, F. R., Tahmasebi, S., Shafiee, A., & Hashemi, S. M. (2023) · Inflammopharmacology · doi:10.1007/s10787-022-01115-7 · Cited by 351
PLGA-Based Composites for Various Biomedical Applications
Rocha, C. V., Gonçalves, V., da Silva, M. C., Bañobre-López, M., & Gallo, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042034 · Cited by 350
Alsaab, H. O., Alharbi, F. D., Alhibs, A. S., Alanazi, N. B., Alshehri, B. Y., Saleh, M. A., Alshehri, F. S., Algarni, M. A., Almugaiteeb, T., Uddin, M. N., et al. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14122728 · Cited by 289
Metadata
- Authors
- Ghitman, J., Biru, E. I., Stan, R., & Iovu, H.
- Venue
- Materials & Design
- Publisher
- Elsevier BV
- Published
- 2020-08
- Volume
- 193
- Pages
- 108805
- ISSN
- 0264-1275 (ISSN-L)
- OpenAlex
- W3025080581
- Cited by
- 328
- References
- 130
- FWCI
- 10.59
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.